[New methods for the evaluation of bone quality. Bone Quality Marker.]

Area of Science:

• Biochemistry
• Bone Biology
• Clinical Diagnostics

Background:

• Bone strength is influenced by various biomarkers, including undercarboxylated osteocalcin (ucOC), advanced glycation endproducts (AGEs), and homocysteine.
• These factors are increasingly recognized for their role in defining bone quality and fracture risk.

Purpose of the Study:

• To highlight the growing attention on ucOC, AGEs, and homocysteine as determinants of bone strength.
• To address the current limitations in the measurement of these biomarkers.
• To project the potential impact of improved measurement techniques on clinical practice and bone quality assessment.

Main Methods:

• Review of recent scientific literature focusing on ucOC, AGEs, and homocysteine.
• Analysis of current challenges in the clinical measurement of these bone health indicators.
• Discussion of potential future advancements in biomarker quantification.

Main Results:

• ucOC, AGEs, and homocysteine are identified as significant factors related to bone strength.
• Existing measurement methodologies for these biomarkers present significant challenges.
• Routine clinical application is currently hindered by these measurement issues.

Conclusions:

• Despite their importance for bone quality, ucOC, AGEs, and homocysteine are not yet routinely used in clinical practice due to measurement difficulties.
• Future advancements in measurement techniques are expected to enhance their utility in assessing bone health and guiding clinical decisions.